Call Us Today at 305-405-1595 – Infusion and Immunotherapy Center of South Florida (IICSFL)

Call Us Today at 305-405-1595 | Infusion and Immunotherapy Center of South Florida (IIC)

Infliximab on an HIV Positive Patient with Reiter’s Syndrome

2012-11-19T14:04:34+00:00

Dr. Norman B. Gaylis Reiter's syndrome is an acute inflammatory arthritis with no standard treatment options for patients unresponsive to nonsteroidal antiinflammatory drugs (NSAID). In patients positive for Human Inmunodeficiency Virus (HIV), HIV-RNA levels have been correlated with elevated tumor necrosis factor-α (TNF-α) levels. We investigated the safety and actvitiy of infliximab, an anti-TNF-α chimeric [...]

Infliximab on an HIV Positive Patient with Reiter’s Syndrome2012-11-19T14:04:34+00:00

Discontinuation of corticosteroids following initiation of infliximab in RA patients

2012-11-19T14:01:59+00:00

Dr. Norman B. Gaylis Objectives: To evaluate corticosteroid use in patients with refractory rheumatoid arthritis (RA) after initiation of infliximab therapy. Methods: We conducted a retrospective evaluation of 70 patients (5 male, 65 female) in our community rheumatology practice. All patients met the following inclusion criteria: diagnosis of RA consistent with American College of Rheumatology [...]

Discontinuation of corticosteroids following initiation of infliximab in RA patients2012-11-19T14:01:59+00:00

Use of MRI to evaluate patients on infliximab therapy

2012-11-19T13:59:30+00:00

Dr. Norman B. Gaylis, Dr. Steven Needell USE OF IN-OFFICE MRI IN THE EVALUATION OF PATIENTS WITH RHEUMATOID Objectives: To assess the performance of an in-office magnetic resonance imaging (MRI) system in the diagnosis of rheumatoid arthritis (RA) while evaluating the treatment benefit with the anti-TNF-alpha agent infliximab. Methods: Fourteen patients who satisfy the American [...]

Use of MRI to evaluate patients on infliximab therapy2012-11-19T13:59:30+00:00

Study on RA patients who switch to infliximab after etanercept

2012-11-19T13:56:37+00:00

Multicenter Study Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study For the complete article in PDF format, please click here: full article Objective: To incorporate a new trial design to examine clinical response, cytokine expression and joint imaging in patients with rheumatoid [...]

Study on RA patients who switch to infliximab after etanercept2012-11-19T13:56:37+00:00

Changes after one year on RA patients on infliximab therapy

2012-11-19T13:44:23+00:00

N.B. Gaylis, S.D. Needell, D. Rudensky CHANGES IN EROSIVE STATUS DETECTED ON IN-OFFICE MRI AFTER ONE YEAR FOLLOW-UP OF RHEUMATOID ARTHRITIS PATIENTS ON INFLIXIMAB THERAPY Background: Magnetic resonance imaging (MRI) is more sensitive than conventional radiographs in detecting and monitoring changes in bone erosions in response to therapy. MRI can be beneficial in helping to [...]

Changes after one year on RA patients on infliximab therapy2012-11-19T13:44:23+00:00

Cerebritis: a Sequel of Lupus

2012-11-19T13:38:57+00:00

NORMAN B. GAYLIS, ROY D. ALTMAN, STEVEN OSTROV, and ROBERT QUENCER The Selective Value of Computed Tomography of the Brain in Cerebritis Due to Systemic Lupus Erythematosus Abstract.Systemic lupus erythematosus (SLE) and steroid effects on the brain were measured by computed tomography (CT). Of 14 patients with SLE cerebritis, 10 (71%) had marked cortical atrophy [...]

Cerebritis: a Sequel of Lupus2012-11-19T13:38:57+00:00

Open study comparing the results of etanercept and infliximab on patients with rheumatoid arthritis

2012-11-19T13:32:54+00:00

Multicenter Study OPEN, RANDOMIZED STUDY OF RHEUMATOID ARTHRITIS PATIENTS WHO SWITCHED FROM ETANERCEPT TO INFLIXIMAB COMPARED WITH THOSE WHO REMAINED ON ETANERCEPT: CHANGES IN SERUM INFLAMMATORY, BONE, AND CARTILAGE MARKERS CORRELATED WITH EFFICACY Objectives: To evaluate changes in serum markers of inflammation and bone and cartilage metabolism in a randomized, open-label, exploratory study designed to [...]

Open study comparing the results of etanercept and infliximab on patients with rheumatoid arthritis2012-11-19T13:32:54+00:00

RA patients who can not use etanercept may benefit from infliximab

2012-11-19T13:27:26+00:00

Furst, Yocum, Weisman, Troum, Bray, wallace, Gaylis, Ritter, Yeilding, Gilmer INFLIXIMAB PROVIDES ADDITIONAL CLINICAL AND RADIOGRAPHIC BENEFITS IN RA PATIENTS WHO HAVE AN INADEQUATE RESPONSE TO ETANERCEPT Objectives: This multi-center, randomized, open-label, exploratory 30 week study was designed to evaluate whether switching from etanercept (ETA) plus MTX to infliximab (IFX) + MTX provides evidence of [...]

RA patients who can not use etanercept may benefit from infliximab2012-11-19T13:27:26+00:00

Extremity Imaging improves Rheumatoid Arthritis care

2012-11-19T13:24:15+00:00

Nancy Walsh Supplementing standard x-rays with extremity magnetic resonance imaging for the in-office diagnosis and monitoring of patients with rheumatoid arthritis could significantly improve the quality of care, according to Dr. Norman B. Gaylis, a rheumatologist in private practice in Aventura, Fla. With biologic therapy having revolutionized the treatment of rheumatoid arthritis (RA), the key [...]

Extremity Imaging improves Rheumatoid Arthritis care2012-11-19T13:24:15+00:00

Image of the Month: Patient with Ankylosing Spondylitis

2012-11-19T13:18:11+00:00

Kerri Wachter, Rheumatology News This case has been published in Rheumatology News as the Image of the Month December 2007. Click here for the full article and images. CASE DESCRIPTION The boy had back pain for more than a year. Neither physical therapy nor anti-inflammatory drugs had helped. He had no significant history of injury [...]

Image of the Month: Patient with Ankylosing Spondylitis2012-11-19T13:18:11+00:00
Go to Top